Publication year
2018Source
Nederlands Tijdschrift voor Tandheelkunde, 125, 5, (2018), pp. 281-286ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Oral and Maxillofacial Surgery
Anesthesiology
Journal title
Nederlands Tijdschrift voor Tandheelkunde
Volume
vol. 125
Issue
iss. 5
Page start
p. 281
Page end
p. 286
Subject
Radboudumc 10: Reconstructive and regenerative medicine RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesAbstract
Fear of treatment by an oral and maxillofacial (OMF) surgeon or the dentist is a widespread and deep-rooted phenomenon. A patient can be taught to cope with dental phobia by means of psychological, cognitive behavioural therapy, but in cases of invasive oral treatment, such therapy may be insufficiently effective. For these invasive procedures, sedation serves as an alternative treatment option. The department of Oral and Maxillofacial Surgery at the Radboud University Medical Centre in Nijmegen, the Netherlands, offers the possibility to utilise intravenous sedation with midazolam (Dormicum(R)) and remifentanil (Ultiva(R)). This results in a reduction in the experience of axiety and pain, which can lead to an anterograde amnesia for the invasive treatment. Procedural sedation and analgesia (PSA) for OMF surgery demonstrate a high level of patient satisfaction, and therefore offer a good alternative treatment to local and general anaesthesia.
This item appears in the following Collection(s)
- Academic publications [234108]
- Faculty of Medical Sciences [89175]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.